Get startedLog in
    Picture of Genmab A/S logo

    GMAB — Genmab A/S News Story

    0.000.00%
    dk flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapFalling Star
    All News

    Brief: Genmab To Submit SBLA To FDA For Epcoritamab Plus Rituximab And Lenalidomide

    Picture of Genmab A/S logoGenmab A/S
    02/05/2025 07:29
    May 2 (Reuters) - Genmab A/S GMAB.CO:

GENMAB TO SUBMIT SUPPLEMENTAL BIOLOGICS LICENSE APPLICATION (SBLA) TO U.S. FOOD AND DRUG ADMINISTRATION FOR EPCORITAMAB PLUS RITUXIMAB AND LENALIDOMIDE (R2) IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (FL)

Source text: ID:nBw59dfhja

Further company coverage: GMAB.CO

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

    Recent news on Genmab A/S

    See all news